2022
DOI: 10.1186/s13578-022-00784-9
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnological engineering of extracellular vesicles for the development of actively targeted hybrid nanodevices

Abstract: Background We propose an efficient method to modify B-cell derived EVs by loading them with a nanotherapeutic stimuli-responsive cargo and equipping them with antibodies for efficient targeting of lymphoma cells. Results The post-isolation engineering of the EVs is accomplished by a freeze–thaw method to load therapeutically-active zinc oxide nanocrystals (ZnO NCs), obtaining the so-called TrojanNanoHorse (TNH) to recall the biomimetism and cytotox… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 69 publications
1
15
0
Order By: Relevance
“…The SWs alone caused a slight decrease in the cell proliferation in adenocarcinoma KB cell line, while the combination with pure ZnO NCs showed an important cytotoxicity. The same result was then reported with the final TNH CD20 nanocostruct, showing remarkable and selective toxicity with SWs directed to leukaemic cancer cells with respect to the healthy lymphocytes (Dumontel, 2022). The observed cytotoxicity could be caused by the combination of various concurrent effects leading to the mechanical injury of the cell structure: (i) an enhanced acoustic bubble cavitation;…”
Section: Stimuli-responsive Hybrid Nanoconstructs For Efficient Thera...supporting
confidence: 78%
See 2 more Smart Citations
“…The SWs alone caused a slight decrease in the cell proliferation in adenocarcinoma KB cell line, while the combination with pure ZnO NCs showed an important cytotoxicity. The same result was then reported with the final TNH CD20 nanocostruct, showing remarkable and selective toxicity with SWs directed to leukaemic cancer cells with respect to the healthy lymphocytes (Dumontel, 2022). The observed cytotoxicity could be caused by the combination of various concurrent effects leading to the mechanical injury of the cell structure: (i) an enhanced acoustic bubble cavitation;…”
Section: Stimuli-responsive Hybrid Nanoconstructs For Efficient Thera...supporting
confidence: 78%
“…Furthermore, the anti CD20 antibody was bioconjugated to the EV surface, creating the final TNH CD20 nanoconstruct. The monodispersed size distribution, the colloidal stability over long time periods of the TNH, its haemocompatibility and biocompatibility were then all successfully assessed; the targeting selectivity of the TNH CD20 towards Daudi cancer cells, sparing healthy B lymphocytes (also CD20 + ) and cancer HL60 cells (which are CD20negative cells) was also efficaciously demonstrated (Dumontel, 2022). With the TNH CD20 weapon prepared against leukaemia cancer cells, we then studied the therapeutic and bioimaging capabilities.…”
Section: Stimuli-responsive Hybrid Nanoconstructs For Efficient Thera...mentioning
confidence: 99%
See 1 more Smart Citation
“…It is then foreseen to load the artificial EVs with active compounds, enabling an advanced function in terms of imaging reporter, diagnostic, or therapeutic activities. Examples of these various functions can derive from the already-reported literature concerning both natural EVs or liposomes, proposing the incorporation of drugs, , genetic materials, organic dyes, aptamers, peptides, and more in general proteins ranging from enzyme to antibodies, and even solid-state nanoparticles of various nature, size, porosities, properties, and functions. …”
Section: A Novel Practical Strategymentioning
confidence: 99%
“…8 Zinc Oxide (ZnO) nanoparticles (NPs) are very promising for anticancer applications because they can induce the generation of reactive oxygen species (ROS) and thus oxidative stress that leads to antimicrobial activity. 9 Recently, an innovative hybrid nanosystem including stimuli-responsive ZnO nanoparticles coated with extracellular vesicles (EVs) equipped with antibodies has been engineered by Dumontel and coworkers 10 to reach the target cells more effectively. This nano construct improved the therapeutic effects, 11 relying on the combined actions of ZnONPs and the monoclonal antibody carried on the EV shell.…”
Section: Introductionmentioning
confidence: 99%